A detailed history of Hussman Strategic Advisors, Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Hussman Strategic Advisors, Inc. holds 6,300 shares of UTHR stock, worth $2.29 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares
6,300
Holding current value
$2.29 Million
% of portfolio
0.59%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$311.04 - $363.55 $1.96 Million - $2.29 Million
6,300 New
6,300 $2.26 Million
Q2 2023

Aug 03, 2023

BUY
$205.19 - $232.99 $1.91 Million - $2.17 Million
9,300 New
9,300 $2.05 Million
Q1 2022

May 04, 2022

SELL
$166.16 - $213.96 $432,016 - $556,296
-2,600 Closed
0 $0
Q4 2021

Jan 31, 2022

SELL
$184.32 - $216.08 $92,160 - $108,040
-500 Reduced 16.13%
2,600 $562,000
Q3 2021

Nov 01, 2021

SELL
$179.86 - $214.88 $737,426 - $881,008
-4,100 Reduced 56.94%
3,100 $572,000
Q2 2021

Aug 03, 2021

SELL
$170.47 - $211.93 $613,692 - $762,948
-3,600 Reduced 33.33%
7,200 $1.29 Million
Q1 2021

May 03, 2021

BUY
$153.94 - $174.85 $92,364 - $104,910
600 Added 5.88%
10,800 $1.81 Million
Q4 2020

Feb 01, 2021

SELL
$101.87 - $151.79 $1.56 Million - $2.32 Million
-15,300 Reduced 60.0%
10,200 $1.55 Million
Q3 2020

Nov 02, 2020

BUY
$99.9 - $121.13 $2.55 Million - $3.09 Million
25,500 New
25,500 $2.58 Million
Q4 2019

Jan 31, 2020

SELL
$78.31 - $95.34 $783,100 - $953,400
-10,000 Closed
0 $0
Q3 2019

Oct 31, 2019

SELL
$74.85 - $85.99 $1.12 Million - $1.29 Million
-15,000 Reduced 60.0%
10,000 $798,000
Q1 2019

May 01, 2019

BUY
$107.15 - $126.84 $2.68 Million - $3.17 Million
25,000 New
25,000 $2.93 Million
Q1 2018

May 01, 2018

SELL
$107.21 - $151.94 $1.07 Million - $1.52 Million
-10,000 Closed
0 $0
Q4 2017

Jan 31, 2018

BUY
$118.58 - $151.28 $1.19 Million - $1.51 Million
10,000
10,000 $1.48 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.5B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Hussman Strategic Advisors, Inc. Portfolio

Follow Hussman Strategic Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hussman Strategic Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hussman Strategic Advisors, Inc. with notifications on news.